CEUnits – continuing education at home
CEUnits – continuing education at home
Facebook-f Linkedin-in
0
Your Cart
No products in the cart.

MFT / LCSW

Integrating Treatment for People with Co-Occurring Alcohol and Other Drug, Medical, & Mental Health

1.75 - CE credit hours training

$10.50 - Cost of course

This page contains important information about the course, including training details, a comprehensive course description, learning objectives, and source references. We encourage you to review each section to gain a clear understanding of the course content, educational goals, and supporting materials before beginning your training and taking the POST TEST below.

Target audience and instructional level of this course: foundational
There is no known conflict of interest or commercial support related to this CE program.

Integrating Treatment for People with Co-Occurring Alcohol and Other Drug, Medical, & Mental Health

Follow the link below, read the material and then take the 18 question post test

Read the Course Material:
Integrating Treatment for People with Co-Occurring Alcohol and Other Drug, Medical, & Mental Health

18 Questions

1. From "Scope of the Problem": Amongst people with AUDs psychiatric problems and severity are associated with:
2. From "Integrating Treatment: Co-Occurring Mental Health": There has been an increase in the availability of 12 step-oriented self-help groups adapted to meet the special needs of people with CODs. The initial evidence indicates:
3. From "Integrating Treatment: Co-Occurring AOD Problems and Medical Conditions": Traditionally, many primary care providers rarely screen for or discuss AOD use with their patients and they were not commonly considered the appropriate health care professional to handle treatment for AOD use problems. Which of the following reasons are cited for this circumstance?
4. From "Integrating Treatment: Co-Occurring AOD Problems and Medical Conditions": Which of the following factor(s) does the article cite that may help increase successful integration of AOD services into medical settings?
5. From "Barriers to Integration": Which of the following barriers to integration is cited?
6. From "Models of Treatment": According to the article, there is not enough evidence to determine which model of treatment is most effective for patients with CODs.
7. From "Fully Integrated Treatment- Is that the goal?": The Timko (2005) study found that ______________ programs were more likely to provide services for CODs than were ____________ programs.
8. From "Fully Integrated Treatment- Is that the goal?": The article asserts that confidentiality laws pertaining to persons with AODs make coordination of care for COD patients particularly challenging.
9. From "Fully Integrated Treatment- Is that the goal?": The Institute of Medicine (IOM) has published "Recommendations for Implementing Quality Integrated Care for Individuals With Co Occurring Disorders (CODs)". Which of the following is NOT included in their recommendations?
10. From "Discussion": Most research and program development have focused on patients with co-occurring:
11. From "Discussion": The ____________________ emphasizes a continuum of chemical dependency and mental health services based on the combined severity of co-occurring AOD and mental health problems.
12. From "Prevalence and Clinical Impact-Anxiety and AUDs": In epidemiological samples which anxiety disorder was most strongly associated with AUDs?
13. From "Development of Comorbid Anxiety and AUDs-Self-Medication Model": Timelines gathered in community surveys show that ____________ often predate the development of ______________.
14. From "Development of Comorbid Anxiety and AUDs-Substance-Induced Anxiety Model": The evidence for the three proposed causal models for the co-occurrence of anxiety disorders and AUDs (common factor, self-medication, substance-induced anxiety) do not unequivocally point to one pathway for the joint development of anxiety disorders and AUDs.
15. From "Pharmacotherapy for Anxiety": Why should serotonergic-based medicines be used with caution during alcohol withdrawal?
16. From "Psychotherapy of AUDs": According to the article, individuals with co-occurring alcohol and anxiety disorder seem to be especially motivated about changing their alcohol use.
17. From "Application of Treatment Methods-The Sequential Approach": In the Thomas et al. (2008) study of paroxetine for comorbid social anxiety and AUDs found:
18. From "Application of Treatment Methods-The Integrated Approach": How would you describe the state of the integrated approach for co-occurring anxiety and AUDs?
Most people with alcohol and other drug (AOD) use disorders suffer from co-occurring disorders (CODs), including mental health and medical problems, which complicate treatment and may contribute to poorer outcomes. This course addresses existing models for treating CODs at the treatment and the systems levels. Barriers that impede further integration of care for patients with CODs are addressed. The development of co-morbid anxiety and alcohol use disorders is explored, as well as evidence regarding treatment approaches for these common CODs.
  • identify a variety of models for treating co-occurring disorders.
  • describe barriers to coordinated or integrated care for CODs.
  • describe the evidence regarding the development of co-morbid anxiety and alcohol use disorders.
  • summarize evidence for a variety of treatments for anxiety and alcohol use disorders.
STACY STERLING, M.P.H., M.S.W.,
Group Leader; Division of Research, Kaiser Permanente Medical Care Program, Oakland, California.
FELICIA CHI, M.P.H.
Senior Analyst
Division of Research, Kaiser Permanente Medical Care Program, Oakland, California

AGATHA HINMAN
Research Associate
Division of Research, Kaiser Permanente Medical Care Program, Oakland, California